Jon S. Halbert's most recent trade in Caris Life Sciences Inc. - Ordinary Shares - Class A was a trade of 13,192 Common Stock done . Disclosure was reported to the exchange on Aug. 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caris Life Sciences Inc (Class A) | Mr. Jon S. Halbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2026 | 13,192 | 131,813 | - | 0 | Common Stock | |
| Caris Life Sciences Inc (Class A) | Mr. Jon S. Halbert | Director | Purchase of securities on an exchange or from another person at price $ 14.56 per share. | 15 May 2026 | 68,000 | 704,598 | - | 14.6 | 990,080 | Common Stock |
| Caris Life Sciences Inc (Class A) | Mr. Jon S. Halbert | Director | Grant, award, or other acquisition of securities at price $ 20.06 per share. | 26 Feb 2026 | 2,492 | 118,621 | - | 20.1 | 49,990 | Common Stock |
| Caris Life Sciences Inc (Class A) | Mr. Jon S. Halbert | Director | 27 Feb 2025 | 5,000,000 | 0 | - | - | Series A Preferred Stock | ||
| Caris Life Sciences Inc (Class A) | Mr. Jon S. Halbert | Director | 27 Feb 2025 | 1,250,000 | 1,250,000 | - | 0 | Common Stock | ||
| Caris Life Sciences Inc (Class A) | Mr. Jon S. Halbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 16,129 | 116,129 | - | 0 | Common Stock |